Clinical Trials on H1N1 Flu in United Kingdom

Total 125 results

Fraunhofer, Center for Molecular Biotechnology
Walter Reed Army Institute of Research (WRAIR); Defense Advanced Research Projects...

Completed

Study of the Safety and Immunogenicity of H1N1 Vaccine

H1N1 Flu

United States
St. Jude Children's Research Hospital

Completed

Immunogenicity and Safety of Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine in Immunocompromised Children and Young Adults

H1N1 Pandemic Flu

United States
Aarogyam UK

Completed

Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak

Flu Like Symptom | Flu Like Illness

United Kingdom
Aarogyam UK

Completed

Ayurveda for Flu Like Illness During Covid-19 Outbreak

Flu Like Illness

United Kingdom
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Influenza | HIV-1 Infection | Flu | H1N1

United States, Puerto Rico
University of Pennsylvania
National Institute on Aging (NIA); University of Washington

Active, not recruiting

Behavioral Economics to Improve Flu Vaccination Using EHR Nudges (BE IMMUNE)

Flu | Behavior, Health | Flu Vaccination

United States
SAb Biotherapeutics, Inc.
Hvivo

Active, not recruiting

Study of SAB-176 in Healthy Adult Participants

Influenza A H1N1

United Kingdom
Hvivo
Pfizer

Completed

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Influenza A H1N1

United Kingdom
Cardiff University

Completed

Study to Investigate the Effects of Hot Drinks on Nasal Airway Resistance and Symptoms of Common Cold

Common Cold/Flu

United Kingdom
David H. Canaday
National Institute of Allergy and Infectious Diseases (NIAID); Brown University and other collaborators

Completed

FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care

Flu

United States
University of Pennsylvania

Completed

Licensing Flu Shot Study

Flu

United States
University of Nottingham

Completed

Virus Shedding and Environmental Deposition of a Novel Influenza Virus

Novel (H1N1) Influenza

United Kingdom
FluGen Inc

Completed

Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers

Flu

United States
Hackensack Meridian Health
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Terminated

PET-CT Scans in Healthy Volunteers After Flu Vaccination (Pro00000226)

Flu

United States
Franklin Health Research
Artemis International; IPRONA

Recruiting

Elderberry for Immune Support

COVID-19 | Flu | Cold | Upper Respiratory Tract Infection | Flu Like Illness

United States
Professor Adrian Covic
Falcon Trading Iasi; Romanian Academy of Medical Sciences

Unknown

Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays (AI-COVID-Xr)

COVID-19 | Pneumonia, Viral | Pneumonia, Ventilator-Associated | Flu Symptom | Flu Like Illness | Influenza With Pneumonia | Pneumonia, Interstitial | Pneumonia Atypical

Italy, Romania, United Kingdom
M.D. Anderson Cancer Center

Recruiting

Impact of High Dietary Fiber on Microbiome and Vaccine Responses

Flu | Microbiome

United States
Vanderbilt University Medical Center

Completed

Senescent Immunity in Elders and Vaccine Responses (SILVER)

Flu Vaccine

United States
Avila Herbals

Unknown

Evaluation of the Safety and Pharmacokinetics of Oleander 4X in Healthy Volunteers

Flu-like Symptoms

United States
Christine Hunter
Merz North America, Inc.

Completed

Flu-Like Symptoms as a Complication of Botulinum Toxin Therapy

Flu-like Symptoms

United States
Kemin Foods LC

Completed

Efficacy of a Whole Cell Algae Fermentate on Gut Health and Overall Immune Function in Healthy Adults With Mild Gastrointestinal Issues

Healthy | Gastrointestinal Dysfunction | Flu Symptom | Cold Symptom

United States
Carnegie Mellon University
University of Pennsylvania; Rutgers University

Completed

Non-integrated Costs Increase Effectiveness of Incentives

Control - No Incentive for Flu Vaccine | Direct Incentive | Indirect Incentive

United States
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Open-Label Study of Recombinant DNA Plasmid Vaccine, VRC-AVIDNA036-00-VP, Encoding for Influenza Virus H5 Hemagglutinin Protein Given Intradermally

Influenza A Virus, H5N1 Subtype | Influenza A Virus | Influenzavirus A | H5N1 Virus | Orthomyxovirdae

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Avian Flu Vaccine

Influenza A Virus, H5N1 Subtype | Influenza A Virus | Influenzavirus A | Orthomyxoviridae | H5N1 Virus

United States
Medicago

Completed

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Flu

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Corona Virus Infection | Immunity | Flu Vaccine

United States
Diassess Inc.

Completed

Clinical Performance of the Diassess Influenza A and B Test

Influenza | Influenza, Human | Flu

United States
Harvard University
National Institute on Aging (NIA); Massachusetts Institute of Technology; Ludwig-Maximilians...

Completed

Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects

Covid19 | Influenza, Human | Flu, Human

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

H5N1 Influenza

United States
Brigham and Women's Hospital
Department of Health and Human Services; Centers for Medicare and Medicaid... and other collaborators

Completed

Mail Outreach To Increase Vaccination Acceptance Through Engagement (MOTIVATE)

Influenza | Influenza, Human | Human Flu

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines

Influenza | Flu

United States
University of Rochester
National Institutes of Health (NIH)

Withdrawn

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children (H1N1Children)

2009 H1N1 Influenza

United States
National Institute of Allergy and Infectious Diseases...

Completed

Experimental AD4-H5-VTN Vaccine in Healthy Volunteers

H5N1 Influenza

United States
University of Rochester
National Institutes of Health (NIH)

Completed

Effects of Age on Response to the 2009 H1N1 Virus Vaccine

2009 H1N1 Influenza Virus

United States
Novartis Vaccines
Novartis Vaccines and Diagnostics (formerly Chiron Vaccines)

Completed

Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults

Influenza Disease; Flu

United States
National Institute of Allergy and Infectious Diseases...
Emory University

Completed

Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03)

Influenza A Virus, H5N1 Subtype

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...

Influenza A Virus, H5N1 Subtype

United States
National Institute of Allergy and Infectious Diseases...

Completed

Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model (CR6261)

H1N1 Influenza Healthy Volunteers

United States
Virginia Commonwealth University

Completed

Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza

Seasonal Influenza | H1N1 Influenza

United States
IDRI
Defense Advanced Research Projects Agency; Medicago

Completed

H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers

Influenza A Subtype H5N1 Infection

United States
GlaxoSmithKline

Completed

Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days (NAI113625)

Influenza A Virus, H1N1 Subtype

United States
Novartis Vaccines
Department of Health and Human Services

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children

Pandemic H5N1 Influenza

United States, Thailand
Novartis Vaccines
Department of Health and Human Services

Completed

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Pandemic H5N1 Influenza

United States, Australia, Thailand
National Institute of Allergy and Infectious Diseases...

Completed

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Influenza | Avian Influenza | H1N1 Influenza

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

A Study of the Pharmacology of Tamiflu in Pregnancy

H1N1 Influenza Treatment During Pregnancy

United States
Ology Bioservices

Completed

Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults

Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine

United States
Emergent BioSolutions

Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

Influenza | Bird Flu

United States
Biomedical Advanced Research and Development Authority
PPD

Completed

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

A/Vietnam/H5N1 Influenza Virus

United States
National Institute of Allergy and Infectious Diseases...

Completed

VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old

Influenza A Virus, H1N1 Subtype | Novel Swine-Origin

United States
Vaxart

Completed

Safety Study of an Oral Vaccine to Prevent Avian Influenza (H5N1)

Avian Influenza | Bird Flu

United States

Clinical Trials on H1N1 Flu in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations